Abstract
In the present preliminary study, we developed a protocol for the acquisition and fusion of dual isotope tomographic (SPECT) images (111In-Octreotide SPECT and 99mTc-HMDP SPECT). This procedure was performed in ten consecutive patients, and the first results were encouraging: it proved to be a simple and accurate method to improve the anatomic localization of 111In-Octreotide SPECT positive foci for the staging and follow-up of tumours expressing somatostatin receptors (Octreotide is an analog of somatostatin), particularly in discriminating bone metastases from soft tissue metastases located near to bone itself.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 133-135 |
| Number of pages | 3 |
| Journal | Minerva Biotecnologica |
| Volume | 20 |
| Issue number | 3 |
| State | Published - Sep 2008 |
Keywords
- Bone neoplasms, secondary
- Emission-computed, single-photon
- In-octreotide
- Isotope
- Neoplasm metastasis
- Tomography
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Applied Microbiology and Biotechnology
Fingerprint
Dive into the research topics of 'A simultaneous dual-isotope acquisition and imaging fusion protocol in nuclear medicine: 111In-Octreotide SPECT and 99mTC-HMDP bone SPECT'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS